Effect of Airway Integrated Nasal Packing With Different Material

March 23, 2012 updated by: Yung-Song Lin, Chi Mei Medical Hospital

Comparison of Nasal Packing Methods:Nasal Packing Was Done With Nasopore@, Airway-integrated Nasopore@ and Airway-integrated Vaseline Gauze

The purpose of this study is to determine the effect of integrated airway in nasal packing material foe patients receiving nasal septoplasty surgery.

Study Overview

Detailed Description

Nasal packing with integrated airway had been claimed to improve body oxygenation following septal surgery. This randomized control study examined the effect of airway integrated with nasal packing, in terms of its improvement on oxygen saturation. Sixty patients with septal deviation and hypertrophic turbinate were randomized into three groups. Group 1 patients were packed with only nasopore@ after surgery. Nasopore@ with integrated airway was used for group 2 patients; and Vaseline gauze integrated with airway for group 3 patients. Hemodynamic parameters were sequentially checked. Nasal pain sensation was recorded using visual analog scale.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan, 70014
        • Chi Mei Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who underwent septoplasty for septal deviation and chronic hypertrophic rhinitis

Exclusion Criteria:

  • patients with comorbidities of coronary heart disease, arrhythmia, chronic obstructive lung diseases, and with past history of any nasal surgery were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nasopore only
Packing using nasopore without airway integrated
Bilateral nasal packing using Nasopore without airway integrated
Active Comparator: nasopore with airway integrated
packing using airway integrated nasopore
post nasoseptoplasty with nasal packing using airway integrated Nasopore
Active Comparator: airway-integrated Vaseline gauze
Nasal packing using airway-integrated Vaseline gauze
post nasal septoplasty with packing using airway-integrated Vaseline gauze

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxyhemoglobin saturation by pulse oximetry, SpO2
Time Frame: SpO2 was measured 30 minutes before operation,
SpO2 was measured 30 minutes before operation using O2 saturation monitor.
SpO2 was measured 30 minutes before operation,
change of SpO2 from baseline to 4 hours post-operation
Time Frame: records of the SpO2 at 4 hours post-operation
records of the SpO2 at 4 hours post-operation
records of the SpO2 at 4 hours post-operation
change of the SpO2 from baseline to 6 hours post-operation
Time Frame: records of the SpO2 at 6 hours post-operation
records of the SpO2 at 6 hours post-operation
records of the SpO2 at 6 hours post-operation
change of the SpO2 from baseline to 12 hours post-operation
Time Frame: records of the SpO2 at 12 hours post-operation
records of the SpO2 at 12 hours post-operation
records of the SpO2 at 12 hours post-operation
change of the SpO2 from baseline to 18 hours post-operation
Time Frame: records of the SpO2 at 18 hours post-operation
records of the SpO2 at 18 hours post-operation
records of the SpO2 at 18 hours post-operation
change of the SpO2 from baseline to 48 hours post-operation
Time Frame: records of the SpO2 at 48 hours post-operation
records of the SpO2 at 48 hours post-operation
records of the SpO2 at 48 hours post-operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperation pain
Time Frame: record of postoperation pain scale at 2 hous post operation
record of postoperation pain scale at 2 hours post-operation
record of postoperation pain scale at 2 hous post operation
change of postoperation pain scale from baseline to 4 hours post-operation
Time Frame: record of postoperation pain scale at 4 hours post-operation
record of postoperation pain scale at 4 hours post-operation
record of postoperation pain scale at 4 hours post-operation
change of postoperation pain scale from baseline to 6 hours post-operation
Time Frame: Record of postoperation pain scale at 6 hours post-operation
record of postoperation pain scale at 6 hours post-operation
Record of postoperation pain scale at 6 hours post-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yung-Song Lin, M.D., Chi Mei Medical Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2009

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

March 21, 2012

First Submitted That Met QC Criteria

March 23, 2012

First Posted (Estimate)

March 26, 2012

Study Record Updates

Last Update Posted (Estimate)

March 26, 2012

Last Update Submitted That Met QC Criteria

March 23, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Respiratory Complications

Clinical Trials on Nasopore

3
Subscribe